You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — Oncore Pharma said today that it has partnered with Dutch medical testing firm BodyCheck to commercialize the ColonSentry colorectal cancer test in Belgium, the Netherlands, and Luxembourg in a deal valued at $61.8 million.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.